Skip to main content

Find Clinical Trials

Home
Conditions
Parasomnias

Clinical trial condition

Parasomnias

Explore clinical trials studying Parasomnias. Study availability and eligibility vary by location and protocol.

314 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Parasomnias trial results

Completed

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

NCT01411124

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine

NCT01476124

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.

NCT00298623

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

NCT01113710

Conditions: Dyssomnias, Idiopathic Restless Legs Syndrome, Mental Disorders, +5 more
Locations: Abensburg, Germany

Altenholz, Germany

Alzenau in Unterfranken, Germany

Anklam, Germany

View all 80 locations

View Trial Details

Completed

Suggested Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of Concept

NCT00867893

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

NCT00357097

Conditions: Behavior, Behavioral Symptoms, Depression, +8 more
Locations: GSK Investigational Site Ellwangen, Baden-Wurttemberg, Germany

GSK Investigational Site Freiburg im Breisgau, Baden-Wurttemberg, Germany

GSK Investigational Site Ostfildern, Baden-Wurttemberg, Germany

GSK Investigational Site Ulm, Baden-Wurttemberg, Germany

View all 50 locations

View Trial Details

Completed

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

NCT00349531

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: 248.615.45103 Boehringer Ingelheim Investigational Site Kongens Lyngby, Denmark

248.615.45102 Boehringer Ingelheim Investigational Site København K, Denmark

248.615.45101 Boehringer Ingelheim Investigational Site København NV, Denmark

248.615.45104 Boehringer Ingelheim Investigational Site Vaerløse, Denmark

View all 49 locations

View Trial Details

Completed

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

NCT00356096

Conditions: Behavior, Behavioral Symptoms, Depression, +7 more
Locations: 248.604.35801 Boehringer Ingelheim Investigational Site Espoo, Finland

248.604.35805 Boehringer Ingelheim Investigational Site Helsinki, Finland

248.604.35803 Boehringer Ingelheim Investigational Site Lahti, Finland

248.604.35802 Boehringer Ingelheim Investigational Site Oulu, Finland

View all 54 locations

View Trial Details

Completed

Botulinum Toxin to Treat Restless Legs Syndrome

NCT00479154

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

NCT00367822

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: IMEREM GmbH Nuremberg, Germany

View Trial Details